Visión generalGráficoNoticiasTraderScreen

UC WAR. CALL 09/24 OMV/  DE000HC9XQT7  /

gettex
30/05/2024  11:45:40 Diferencia+0.0010 Bid12:09:21 Ask- Subyacente Precio de ejercicio Fecha de expiración Tipo de opción
0.0020EUR +100.00% 0.0020
Volumen de oferta: 100,000		 -
Tamaño/ Volumen/ Formato de Ask: -		 OMV AG 55.00 - 18/09/2024 Call
GlobeNewswire 13:05 Vigil Neuroscience to Present in Upcoming June Investor Conferences
GlobeNewswire 13:02 Incident IQ Partners with Level Access to Enhance Digital Accessibility
TeleTrader 13:01 Best Buy's Q1 revenue down 6.5% to $8.8B
GlobeNewswire 13:00 Elevar Therapeutics Reports Landmark Median Overall Survival of 23.8 Months in First-Line Treatment ...
GlobeNewswire 13:00 Omega Therapeutics To Participate In Two Upcoming Investor Conferences
GlobeNewswire 13:00 Troilus Discovers New At-Surface Gold Zone ‘West Rim’ With Intercept of 1.37 g/t AuEq Over 11m Withi...
GlobeNewswire 13:00 BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conf...
GlobeNewswire 13:00 Destination XL Group, Inc. Reports First Quarter Financial Results
GlobeNewswire 13:00 PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in June
Newsfile Corp 13:00 UFC and Aires Tech Announce Multi-Year Global Marketing Partnership
GlobeNewswire 13:00 Beamr Cloud upgrade for enterprises: customizable video service with enhanced security and privacy
GlobeNewswire 13:00 Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research
GlobeNewswire 13:00 Amplify ETFs Declares May Income Distributions for its ETFs
GlobeNewswire 13:00 SERB Pharmaceuticals appoints Vanessa Wolfeler as CEO to drive next stage of the company’s growth
GlobeNewswire 13:00 Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis ...
GlobeNewswire 13:00 SPOD Lithium Provides a Strategic Update
GlobeNewswire 13:00 17 Education & Technology Group Inc. to Report First Quarter 2024 Unaudited Financial Results on Jun...
GlobeNewswire 13:00 Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and P...
GlobeNewswire 13:00 Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Trea...
GlobeNewswire 13:00 Rivalry Reports First Quarter 2024 Results, Expands Into Crypto Segment Through Rivalry Token
GlobeNewswire 13:00 Virtu Financial, Inc. Announces Investor Meetings for Potential Opportunistic Offering of Senior Sec...
GlobeNewswire 13:00 Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Poster Presentation at Federati...
GlobeNewswire 13:00 Axsome Therapeutics to Participate in Upcoming Investor Conferences
GlobeNewswire 13:00 Village Farms International Boosts Ownership in Fast-Growing Rose LifeScience
GlobeNewswire 13:00 ARMLOGI ANNOUNCES EXPANSION AT THE PORT OF SAVANNAH